Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 383,745 | 217,442 | 402,438 | 333,554 | 543,064 |
| Marketable Securities | 1,641,934 | 1,714,066 | 1,734,733 | 1,769,121 | 1,746,235 |
| TOTAL | $2,075,037 | $1,977,489 | $2,176,439 | $2,134,582 | $2,327,632 |
| Non-Current Assets | |||||
| PPE Net | 33,194 | 32,926 | 33,049 | 27,153 | 24,289 |
| Investments And Advances | 24,148 | 16,851 | 0 | 0 | 12,128 |
| Intangibles | 70,408 | 70,477 | 70,744 | 71,011 | 71,278 |
| Other Non-Current Assets | 151,721 | 154,177 | 149,336 | 132,607 | 122,974 |
| TOTAL | $279,471 | $274,431 | $253,129 | $230,771 | $230,669 |
| Total Assets | $2,354,508 | $2,251,920 | $2,429,568 | $2,365,353 | $2,558,301 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 64,616 | 74,849 | 56,761 | 47,507 | 54,427 |
| Accrued Expenses | 209,340 | 154,447 | 114,685 | 98,113 | 96,615 |
| TOTAL | $290,424 | $245,622 | $184,534 | $158,599 | $163,914 |
| Non-Current Liabilities | |||||
| Long Term Debt | 268,446 | 256,509 | 245,081 | N/A | N/A |
| Other Non-Current Liabilities | 161,988 | 150,532 | 132,231 | 126,251 | 126,830 |
| TOTAL | $432,787 | $409,394 | $379,665 | $128,604 | $129,183 |
| Total Liabilities | $723,211 | $655,016 | $564,199 | $287,203 | $293,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 198,173 | 193,320 | 186,933 | 186,268 | 185,913 |
| Common Shares | 19 | 18 | 18 | 18 | 18 |
| Retained earnings | -2,869,102 | -2,504,210 | -2,199,004 | -1,951,217 | -1,737,801 |
| Other shareholders' equity | 3,237 | 3,116 | 1,302 | 1,707 | 1,321 |
| TOTAL | $1,631,297 | $1,596,904 | $1,865,369 | $2,078,150 | $2,265,204 |
| Total Liabilities And Equity | $2,354,508 | $2,251,920 | $2,429,568 | $2,365,353 | $2,558,301 |